Skip to main content
SpringerLink
Log in

Assessment of listing criteria for lung transplant candidates with interstitial lung disease

  • Original Article
  • Published:
General Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Objectives

Lung transplantation (LT) is an effective treatment for patients with interstitial lung disease (ILD) refractory to medical treatment. Although the cases of cadaveric LT (CLT) have increased, the donor shortage in Japan has remained severe. This study aimed to evaluate the International Society of Heart and Lung Transplantation (ISHLT) listing criteria for LT in patients with ILD by predicting outcomes during the waiting time for CLT.

Methods

We retrospectively identified 166 patients with fibrotic ILDs who were evaluated and registered for CLT at Kyoto Universal Hospital from April 1, 2008, to December 31, 2017. We examined the correlation between individual parameters of the ISHLT listing criteria and patient outcomes.

Results

Among 166 patients, 57 (34.3%) underwent CLT, whereas 83 (50.0%) died before CLT. The median survival time from the date of registration was 22.5 months. The 2-year survival rate was 47.8%. On multivariate Cox proportional hazards analysis, relative decline of percent predicted forced vital capacity (%FVC) in 6 months ≥ 10% (hazard ratio [HR]: 1.72; 95% confidence interval [95%CI]: 1.03–2.87, p = 0.04) and 6-min walking distance (6MWD) < 250 m (HR: 2.77; 95%CI: 1.64–4.69, p < 0.001) were independently associated with worse outcome (i.e., death or living-donor lobar LT).

Conclusions

The 2014 ISHLT criteria could appropriately identify patients with ILD who have a potentially poor prognosis. In particular, 6-month decline in %FVC and shorter 6 min walk distance may be useful for selecting patients with higher risks of mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788–824.

    Article  Google Scholar 

  2. Date H. Current status and problems of lung transplantation in Japan. J Thorac Dis. 2016;8(5):S631–6.

    Article  Google Scholar 

  3. Sato M, Okada Y, Oto T, Minami M, Shiraishi T, Nagayasu T, et al. Registry of the Japanese society of lung and heart-lung transplantation: official Japanese lung transplantation report, 2014. Gen Thorac Cardiovasc Surg. 2014;62(10):594–601.

    Article  Google Scholar 

  4. Orens JB, Estenne M, Arcasoy S, Conte JV, Corris P, Egan JJ, et al. International guidelines for the selection of lung transplant candidates: 2006 update-a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Hear Lung Transplant. 2006;25(7):745–55.

    Article  Google Scholar 

  5. Weill D, Benden C, Corris PA, Dark JH, Davis RD, Keshavjee S, et al. A consensus document for the selection of lung transplant candidates: 2014—an update from the pulmonary transplantation council of the International society for heart and lung transplantation. J Hear Lung Transplant. 2015;34(1):1–15.

    Article  Google Scholar 

  6. Leard LE, Holm AM, Valapour M, Glanville AR, Attawar S, Aversa M, et al. Consensus document for the selection of lung transplant candidates: an update from the International society for heart and lung transplantation. J Hear Lung Transplant. 2021;40(11):1349–79.

    Article  Google Scholar 

  7. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–38.

    Article  CAS  Google Scholar 

  8. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories ATS statement: Guidelines for the 6 minute walk test. Am J Respir Crit Care Med. 2002; 166(1): 111–117

  9. Zappala CJ, Latsi PI, Nicholson AG, Colby TV, Cramer D, Renzoni EA, et al. Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis. Eur Respir J. 2010;35(4):830–5.

    Article  CAS  Google Scholar 

  10. Hanson D, Winterbauer RH, Kirtland SH, Wu R. Changes in pulmonary function test results after 1 year of therapy as predictors of survival in patients with idiopathic pulmonary fibrosis. Chest. 1995;108(2):305–10.

    Article  CAS  Google Scholar 

  11. Hubbard R, Johnston I, Britton J. Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study. Chest. 1998;113(2):396–400.

    Article  CAS  Google Scholar 

  12. Raghu G, Ley B, Brown KK, Cottin V, Gibson KF, Kaner RJ, et al. Risk factors for disease progression in idiopathic pulmonary fibrosis. Thorax. 2020;75(1):78–80.

    Article  Google Scholar 

  13. Snyder L, Neely ML, Hellkamp AS, O’Brien E, de Andrade J, Conoscenti CS, et al. Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO registry. Respir Res. 2019;20(1):1–10.

    Article  CAS  Google Scholar 

  14. Mogulkoc N, Brutsche MH, Bishop PW, Greaves SM, Horrocks AW, Egan JJ. Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation. Am J Respir Crit Care Med. 2001;164(1):103–8.

    Article  CAS  Google Scholar 

  15. Montgomery E, Macdonald PS, Newton PJ, Chang S, Jha SR, Hannu MK, et al. Frailty as a predictor of mortality in patients with interstitial lung disease referred for lung transplantation. Transplantation. 2020;104(4):864–72.

    Article  Google Scholar 

  16. Higo H, Kurosaki T, Ichihara E, Kubo T, Miyoshi K, Otani S, et al. Clinical characteristics of Japanese candidates for lung transplant for interstitial lung disease and risk factors for early death while on the waiting list. Respir Investig. 2017;55(4):264–9.

    Article  Google Scholar 

  17. Du Bois RM, Albera C, Bradford WZ, Costabel U, Leff JA, Noble PW, et al. 6 minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis. Eur Respir J. 2014;43(5):1421–9.

    Article  Google Scholar 

  18. Lederer DJ, Arcasoy SM, Wilt JS, D’Ovidio F, Sonett JR, Kawut SM. 6 minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2006;174(6):659–64.

    Article  Google Scholar 

  19. Kawut SM, O’Shea MK, Bartels MN, Wilt JS, Sonett JR, Arcasoy SM. Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantation. Respir Med. 2005;99(11):1431–9.

    Article  Google Scholar 

  20. Ikezoe K, Handa T, Tanizawa K, Chen-Yoshikawa TF, Kubo T, Aoyama A, et al. Prognostic factors and outcomes in Japanese lung transplant candidates with interstitial lung disease. PLoS ONE. 2017;12(8):1–13.

    Article  Google Scholar 

  21. Miyahara S, Waseda R, Tokuishi K, Sato T, Iwasaki A, Shiraishi T. Elucidation of prognostic factors and the effect of anti-fibrotic therapy on waitlist mortality in lung transplant candidates with idiopathic interstitial pneumonias. Respir Investig. 2021;59(4):428–35.

    Article  CAS  Google Scholar 

  22. Neizer H, Singh GB, Gupta S, Singh SK. Addressing donor-organ shortages using extended criteria in lung transplantation. Ann Cardiothorac Surg. 2020;9(1):49–50.

    Article  Google Scholar 

  23. The Japanese Society of Lung and Heart-Lung Transplantation. Registry report of Japanese lung transplantation 2020. Transplantation. 2020;55(3):271–6.

    Google Scholar 

Download references

Funding

None declared.

Author information

Authors and Affiliations

  1. Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, Shogoin-Kawara-cho 54, Sakyo-ku, Kyoto, 606-8507, Japan

    Shunichi Nagata, Akihiro Ohsumi, Yoshito Yamada, Satona Tanaka, Yojiro Yutaka, Daisuke Nakajima & Hiroshi Date

  2. Department of Thoracic Surgery, Nagara Medical Center, Gifu, Japan

    Shunichi Nagata

  3. Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan

    Tomohiro Handa, Kiminobu Tanizawa & Toyohiro Hirai

  4. Department of Advanced Medicine for Respiratory Failure, Graduate School of Medicine, Kyoto University, Kyoto, Japan

    Tomohiro Handa

Authors
  1. Shunichi Nagata
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Akihiro Ohsumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tomohiro Handa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoshito Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Satona Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yojiro Yutaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Daisuke Nakajima
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kiminobu Tanizawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Toyohiro Hirai
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Hiroshi Date
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Akihiro Ohsumi.

Ethics declarations

Conflict of interest

None declared.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nagata, S., Ohsumi, A., Handa, T. et al. Assessment of listing criteria for lung transplant candidates with interstitial lung disease. Gen Thorac Cardiovasc Surg 71, 20–26 (2023). https://doi.org/10.1007/s11748-022-01861-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11748-022-01861-z

Keywords

Search

Navigation